INTRODUCTION
============

*Escherichia coli* is the predominant facultative anaerobe of the human colonic flora. The organism typically colonizes the infant gastrointestinal tract within hours of life, and, thereafter, *E. coli* and the host derive mutual benefit \[[@R1]\].Verotoxigenic *Escherichia coli* (VTEC) are named for their ability to produce toxins with a cytopathic effect on Vero cells. They are also referred to as shiga toxin-producing *E coli* (STEC) because their cytotoxins closely resemble the shiga toxin produced by *Shigella dysenteriae* 1. Two types of shiga toxin are produced: shiga toxin 1 (Stx1), which is most closely related to that produced by *S. dysenteriae*, and shiga toxin 2 (Stx2), which has several variants. Entero-hemorrhagic *E coli* (EHEC) are the subgroup of VTEC organisms with demonstrated human pathogenicity. While most VTEC belong to *E coli* serogroup O157, verotoxin production has been identified in more than 200 serogroup \[[@R2]\]. Hemolytic uremic syndrome is the most common cause of acute renal failure in children, and the incidence of this syndrome in children is increasing worldwide \[[@R3]\]. *E. coli* O157:H7 is believed to cause more than 80 percent of the STEC infections that lead to hemolytic uremic syndrome \[[@R4]\]. Hemolytic uremic syndrome primarily occurs in children one to 10 years of age \[[@R5],[@R6]\] with an average annual incidence of one to three cases per 100,000 children \[[@R7]\] and a survival rate of nearly 95 percent. Some studies indicate that rural populations are more at risk than urban populations \[[@R8],[@R9]\] and the incidence is higher in warmer months of year, peaking from June to September \[[@R10]\].

Occurrences may be sporadic or present as an outbreak. A study conducted in the United Kingdom, in which confections intentionally were artificially contaminated with *E. coli* O157:H7 showed that the Shiga toxin-producing strains could survive for as long as one year, depending on storage conditions \[[@R11]\]. Three to 15 percent of persons who have STEC with diarrhea can develop hemolytic uremic syndrome \[[@R12]\]. Young children and older persons with altered immune response, \[[@R13]\] as well as persons who have been in contact with infected farm animals, are particularly vulnerable. In addition to age, risk factors associated with hemolytic uremic syndrome included bloody diarrhea fever, and elevated white blood cell count and C-reactive protein levels \[[@R14]\]. The use of antibiotics or antimotility/antidiarrheal and antimicrobial agents in early stages of diarrhea has been shown to increase the risk of hemolytic uremic syndrome because the gut is exposed to a greater number of toxins for a longer period as intestinal motility slows \[[@R10],[@R15]\]. The pathogen is relatively tolerant to acid and can survive in fermented foods and fresh vegetable produce.

Waterborne transmission has also been reported, both from contaminated drinking-water and from recreational waters. Person-to-person contact is an important mode of transmission, particularly in institutional settings, such as day care centers, nursing homes and hospitals \[[@R16]\]. Reports of EHEC as a cause of diarrhea in other African countries are sporadic. In a study of childhood diarrhea in Nigeria, samples of EHEC were isolated from 5.1% of children with diarrhea \[[@R17]\]. A study from Japan in 1996 by Japan reported 9451 cases of EHEC infections, 1808 of which were hospitalized and 12 died; three-quarters of all these cases occurred during six major outbreaks. In the largest outbreak, in SakaiCity, 5727 people (0.5% of the city\'s population) were affected, and white radish sprouts served at school lunch were the most likely food vehicle. In outbreaks reported in other areas *E. coli* 0157 was also isolated from the salad and seafood sauce that were served at school lunches. In 1997, *E. coli* 0157 was detected in wild venison and white radish sprouts associated with sporadic infections \[[@R16]\]. In other parts of Asia, EHEC infections have been reported. In Malaysia, *E. coli*0157:H7 has been isolated from the stools of patients with diarrheal illness \[[@R18]\]. In a study at a Bangkok hospital in Thailand, EHEC was identified in 7% of children with bloody diarrhea in whom other enteric pathogens were not identified \[[@R19]\]. In the Republic of Korea, EHEC was isolated from 1.3% of children with no bloody diarrhea. An investigation into the etiology of childhood diarrhea in China, EHEC isolated from 6.8% of children with diarrhea \[[@R20]\]. This article will review the diarrheagenic *E. coli* strains, which include several emerging pathogens of worldwide public health importance, and will specifically focus on pathogens afflicting humans. We will particularly concentrate on the *E. coli* strain whose study has advanced most over the last decade, *E. coli* (EHEC). The indications for culturing for EHEC differ from those for the rest of the diarrheagenic *E. coli* categories. Routine screening test for *E. coli* in urine are most often recovered on blood agar and eosin methyleneblue agar, which selectively grow members of the *Enterobacteriaceae* , biochemical test such as TSI,SIM, citrate, Urease were used, and also serologic test with VTEC-RPLA latex agglutination kit production of toxin and multiplex PCR methods used for identifying *vtxB*1- and *vtxA*2 Phenotypes.

MATERIAL AND METHODS
====================

Clinical Specimens
------------------

Overall criteria for diagnosis UTI was growth of ≥10^4^ CFU/mL of a urinar**y** tract pathogen) in patients who did not have another potential source for their fever, a history of UTI, malodorous urine or hematuria, appeared \"ill\", abdominal or suprapubic tenderness on examination, or fever ≥39°C \[[@R25]\]. Patients who had received antibiotic treatment within the preceding 2 weeks, and those with known congenital anomalies of urinary tract or central nervous system-associated anomalies were excluded.

In this \"prospective study\" we collected 12572 urine samples from Children with UTI in Mofid children hospital Tehran, Iran /The age of patients ranged between 1-12 years old. Samples were collected in sterile plastic containers. The samples were inoculated in the Blood agar and EMB. After 24 hours of incubation at 37°C significant isolated microorganisms were identified by using Gram stain, catalase, oxidase, and other conventional tests. Each colonies which have β-hemolysis and Sorbitol fermentation negative on SMAC agar, suspected to EHEC so used Reverse passive Latex Agglutination Method for Detecting and Characterizing Verotoxins (Shiga Toxins) in *Escherichia coli.*

VTEC-RPLA-SEIKEN
----------------

A reverse passive latex agglutination was performed according to the Manufacturer's instructions (No: 230553).

Collection of Samples and Preparation of Template DNA for PCR
-------------------------------------------------------------

A total of 378 *E.coli* were collected over the periods from 1 October 2008 to 31 June 2009. All bacteria plated directly on both blood agar and SMAC agar (Oxoid, Wesel, Germany) and incubated overnight at 37°C. All colonies suspended to

VTEC were diluted in 1 ml of Nutrient broth with 15%glycerol. The suspension was diluted 1:20 in PCR-grade H~2~O (Appli- Chem, Darmstadt, Germany); 1/10 was taken from this mixture for PCR with either a conventional instrument \[[@R21]\].

Extraction of DNA and Detection of STEC Strains by (M-PCR)
----------------------------------------------------------

One mL of bacterial material was suspended in sterile water and heated at 100 °C during 10 min to release DNA. PCR was directly performed using consensus primers amplifying the toxin *vtx*genes Table **[1](#T1){ref-type="table"}**. For each PCR-positive sample, a maximum of 20 colonies obtained on the MacConkey agar plate was tested separately in order to isolate VTEC strains.

Positive *vtx* consensus PCR isolated colonies were subsequently identified through biochemical tests (indole production, Klieger test, ß-glucuronidase activity).The *vtx*1 and *vtx*2 genes were finally detected in sample isolates by the Multiplex-PCR procedure. Each of the primers was used at 20 pM, with 200 mM each deoxynucleoside triphosphates (Boehringer Mannheim, Meyher, France), 2.510X PCR buffer, 2.5 mM MgCl2, and 2 U of *Taq*DNA polymerase (Denmark). Then, 3 min in 95 °C, 35 cycles including, denaturation for 45s at 94 °C, primer annealing for 90s at 58 °C, and extension for 90s at 72 °C and, finally, 7 min incubation at 72 °C in a Corbett Research DNA thermal cycler (Corbett, Australia) were applied. The reaction products were then analyzed by electrophoresis on 1.2% agarose gels with 1% ethidium bromide (Fermentas, Germany). DNA from the reference strain, *E. coli*reference VTEC *E. coli*O157:H7 (ATCC; 43895), and a reagent blank, which contained all components except the template DNA(NTC), were included as positive and negative controls, respectively \[[@R22]\].

RESULTS
=======

Fig. (**[1](#F1){ref-type="fig"}**) shows the pattern and distribution of some pathogens caused UTI. *E. coli*with 47.2%isolate had the highest frequency followed with *Klebsiella oxytoca* with 147 (18.3%) isolate*. Staphylococcus epidermidis* (14.2%), *Pseudomonas aeruginosa* (8.2%), *Proteus mirabilis*(6.4%) and *Staphylococcus aureus* (4.3%), respectively. Approximately 20.9% strains *of E. coli* which isolated from urine were β-hemolytic *E. coli*, 87.67% were SMAC positive and 3% were β-hemolytic and SMAC positive *E. coli* were ETEC.In diagram, as you see, we found only 2.3 % of *E. coli* isolated from urine children with UTI was Enterohemorrhagic. (Figs. **[2](#F2){ref-type="fig"}** and **[3](#F3){ref-type="fig"}**). The result electrophoresis Products seen on gel electrophoresis after multiplex PCR. lane M: ladder, lane 1, 2, 3: *vtx-1* lane 6, 7, 8: *vtx-2* (Fig. **[4](#F4){ref-type="fig"}**).

DISCUSSION
==========

This study confirms *E.coli* O157:H7 as one of the major causative agent of severe UTI in children. Studies have shown that VTEC strain is commonly isolated in hemolytic colitis and hemolytic uremic syndrome belonging to serogroup O157 \[[@R23],[@R24],[@R26]\]. Following this assertion, VTEC is *vtx* on the increase in UTI subjects with 16.7%, while chronic PID of 100% -1 suggest an absolute prevalence and also gynaecological condition given an inference of 100% *vtx* -1 & 2. Then if, *vtx* -1 and *vtx* -1&2 could give such an increasing prevalence, then many of these patients could as well be suffering from undiagnosed life threatening hemorrhagic colitis (HC) and hemolytic uremic syndrome \[[@R23]\]. Very scanty documentation of *E.coli* O157:H7 prevalence in UTI and other renal related diseases could not be obtained. Comparation of data was not possible from other part of the country due to poor documentation.

In our study only 2.3 % of *E.coli* that isolated from children\'s urine with UTI was Enterohemorrhagic. The prevalence of EHEC in Aslani and *et al.,* studies (Institute Pasteur of Iran, Tehran 2008 in stool) and Nazek Al-Gallas (Tunisia,2007 in stool samples) was 44.5%, 11.1% respectively because EHEC is more dominant in stool than urine.

Since the detection of VT represents a rational, serotype independent strategy for the diagnosis of VTEC infections, simple and reliable procedures that allow the detection of VT.

For this purpose, we evaluated the performance of a VTEC-RPLA-SEIKEN assay(An reverse passive latex agglutination Vero Toxigenic *E. coli*, for the detection and characterization of VTx s in *E. coli*culture filtrates. In this study, 44% of *E.coli* was non-verotoxigenic and 56% was verotoxigene. Mohamed Karmali and *et al.,* in 1998 Evaluated a Microplate Latex Agglutination Method (Verotox-F Assay) for Detecting and Characterizing of Verotoxins (Shiga Toxins) in *Escherichia coli*. They examined 68 VT-positive *E. coli* strains and 104 VT-negative strains*E. coli* and conclude that the Verotox-F assay is highly sensitive and specific for the detection and characterization of VTs in culture filtrates of human *E. coli*isolates. The test is rapid, reliable, and easy to perform; its results are easy to interpret; and it should allow testing for VT to become more widely performed. We also used a different method of latex agglutination but the same conclusion \[[@R27]\].

In 1983--2002 in Atlanta, Georgia Brooks and *et al.,* considered Non-O157 Shiga Toxin--Producing *Escherichia coli* infections. They found 61% *stx1*, 22% *stx2*and 17% both *stx1*and *stx2* while, we had 17/3 % *vtx1*, 52/45% *vtx2*and 30/3 both *vtx1*and *vtx2*.This significant different percent is that in our study was on O157 Shiga Toxin--Producing *Escherichia coli* urinary tract Infections \[[@R28]\]. Thus we suggest rapid method for identification of this bacteria and proper treatment to inhibition of unwanted complications.
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###### 

Oligonucleotide Primers Sequences

  Amplification Product Size (bp)   Reference                                                  Sequence (5΄-3΄)                               Primer
  --------------------------------- ---------------------------------------------------------- ---------------------------------------------- -----------
  180                               Paton and Paton (1998) modified by Fitzmaurice J. (2003)   ATAAATCGCCATTCGTTGACTACAGAACGCCCACTGAGATCATC   VT1F VT1R
  255                               Paton and Paton (1998) modified by Fitzmaurice J (2003)    GGCACTGTCTGAAACTGCTCCTCGCCAGTTATCTGACATTCTG    VT2F VT2R

Products seen on gel electrophoresis after multiplex PCR .lane M: ladder, lane 1, 2, 3: *vtx-1* lane 6, 7, 8: *vtx-2.*
